H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...
Rowley Law PLLC is investigating potential securities law violations by Longboard Pharmaceuticals, Inc. and its board of directors concerning the proposed acquisition of the company by H. Lundbeck A/S ...
The S&P 500 rose to a new record high of 5,859 on Monday ahead of key corporate earnings later this week. At the time of writing, the S&P 500 index was 0.8% higher than the previous close. The Dow ...